At 4 weeks after injection of STZ, GFAP immunofluorescence was increased, spreading to the outer nuclear layer compared to the normal control group; this trend continued at 12 weeks after induction of diabetes (both p < 0.001). The gene discussed is GFAP; the disease is diabetes mellitus.